Combination-Based Drug Screening for Induced Oligodendrocyte Differentiation Enables Mechanistic Insight and Identifies Optimal Drug Pairs for Remyelination https://www.biorxiv.org/content/10.1101/2023.07.11.548469v1?med=mas
Combination-Based Drug Screening for Induced Oligodendrocyte Differentiation Enables Mechanistic Insight and Identifies Optimal Drug Pairs for Remyelination https://www.biorxiv.org/content/10.1101/2023.07.11.548469v1?med=mas